Why Shell and Exxon Want Out of Their $8 Billion UK Chemicals Venture

Why Shell and Exxon Want Out of Their $8 Billion UK Chemicals Venture

Shell and ExxonMobil are quietly testing buyer appetite for Infineum, their 50-50 UK-based fuel and lubricant additives joint venture, at an asking price around $8 billion. If a deal lands near that mark, it won't just be another corporate exit. It'll be a loud admission that even profitable specialty chemical businesses don't fit the capital priorities of today's oil and gas supermajors.

Let's be honest about what's happening here. Infineum isn't some struggling industrial orphan losing money in the corner. Headquartered in Oxfordshire and formed back in 1999 by combining Shell and ExxonMobil's additives arms, the company pulls in roughly $700 million to $800 million in annual EBITDA and sells into 90 countries. Management claims its additives show up in about one-third of vehicles on the road globally and roughly 70% of electric vehicles.

So why walk away from a cash-flowing franchise with serious scale? Because capital allocation is a zero-sum game in the boardroom, and upstream barrels and liquefied natural gas currently command far more attention than downstream chemicals.

http://googleusercontent.com/lmdx_content/kkzxnNNrmCQBtQMdPwLTdPeBrYlbrsFeaXTtKHARFtlvMIsFusmOLKilDRKDggbbajXQTheEqqzqPOakyvESPoLZNluivaheKjVmeUQiEYCeyQUkoNMgXVZjiPgwQSXomdLtopTCuHOLd120952


Why Supermajors Are Rethinking Their UK Chemicals Footprint

For decades, integration looked smart on paper. Drill the hydrocarbons, crack the feedstock, blend the additives, sell the finished fluid. Simple, right?

Not anymore. Investors have rewarded capital discipline, share buybacks, and high-margin upstream or LNG growth far more consistently than sprawling chemical footprints. In September 2026, Shell closed its roughly $16.4 billion to $16.5 billion takeover of Canadian producer ARC Resources to expand its Montney gas and liquids position—its biggest acquisition in a decade. Putting tens of billions into core gas and liquids while holding onto non-core chemical stakes sends mixed signals to shareholders.

Shell already signaled its direction well before this sale process surfaced. Back in March 2025, leadership stated plainly that Shell wasn't the best owner for every chemical asset and laid out plans to trim its chemicals exposure by 2030. Across the wider UK chemical and refining scene, pressure has been building from multiple angles—higher energy and compliance costs, shifting global trade flows, and plant rationalizations. Over at Mossmorran in Fife, ExxonMobil's neighbouring Fife Ethylene Plant ended production in early 2026 and entered decommissioning after four decades. While Mossmorran's ethylene cracker is a bulk petrochemical asset rather than Infineum's specialty additives business, both stories point to the same reality: legacy UK chemical operations are getting scrutinized harder than ever.

The Numbers Behind the $8 Billion Tag

An $8 billion price tag on $700 million to $800 million of annual EBITDA implies an earnings multiple of roughly 10 to 11 times. Having followed industrial M&A cycles long enough, that multiple looks reasonable on paper—assuming buyers believe the earnings stream is durable rather than late-cycle.

Bank of America has been brought in as financial adviser to test the waters, though reports emphasize the process is still early and a sale isn't guaranteed. That caveat matters. Back in 2008, Shell and ExxonMobil reviewed a potential sale of Infineum and decided to keep it instead when pricing and financing conditions didn't cooperate. History doesn't repeat itself word for word, yet financing cost and valuation gaps can kill an $8 billion deal fast if lenders turn cautious.

What BP's Castrol Move Signals for Additives

You can't look at Infineum in isolation without glancing at BP's Castrol deal. BP agreed to sell a 65% stake in Castrol to infrastructure investor Stonepeak at an enterprise value of $10 billion, completing the majority stake sale in November 2026.

Castrol is a consumer and commercial lubricant brand rather than a pure-play additives supplier like Infineum, so the business models aren't identical. Still, the parallel is hard to miss. Big oil is willing to hand majority or full control of mature lubricant and fluid businesses to financial sponsors and specialized buyers when valuation multiples cooperate.

Worth watching: A joint venture owned 50-50 by two rival supermajors is often easier for an outside buyer to pry loose than a wholly owned division—provided both parents agree on price and governance terms.


EVs, Hybrids, and the Additives Tug of War

Here's where most casual commentators get tripped up. They hear "electric vehicles" and assume lubricant and additive demand is falling off a cliff tomorrow.

It's a bit messier than that. Pure battery electric vehicles don't need engine oil or combustion fuel detergents, which creates a structural headwind for traditional crankcase lubricants over time. Base oil capacity additions globally have also raised oversupply worries in parts of the value chain.

At the same time, internal combustion engines aren't vanishing overnight across 90 markets, and hybrids still rely on liquid lubrication and thermal management. Plus, electric drivetrains and battery systems need specialized e-fluids and thermal management chemistry. Infineum reorganized in 2024 into two units, carving out a dedicated focus on electrification, battery-related work, and EV e-fluids.

Whether that pivot justifies an $8 billion valuation is the central debate for any bidder. A buyer paying top dollar has to believe growth in EV fluids, industrial applications, and emerging markets offsets gradual erosion in legacy combustion demand. Some analysts will buy that story; others will push for a discount to reflect transition risk.


Who Actually Bids on a UK Additives Business

Private equity firms are the obvious names floated around a carve-out or joint-venture exit of this size. Sponsors like steady cash generation, clear operational levers, and standalone governance—things a 50-50 joint venture sometimes makes harder to execute when two big parents have different timelines.

Strategic buyers could also kick the tires, though antitrust scrutiny and portfolio overlap vary sharply depending on who steps up. Because the process is in its early stages and no deal is locked in, observers shouldn't treat the $8 billion headline number as a finalized sale price.

Practical Next Steps If You Track This Space

If you're an investor, analyst, or supply-chain operator following energy and specialty chemicals, don't stop at the headline valuation:

  1. Track advisor signals and buyer leaks: Watch whether Bank of America's outreach broadens to multiple bidding rounds or stalls over valuation gaps between the sellers and private equity sponsors.
  2. Separate bulk chemicals from specialty additives: Don't lump every UK chemical or refining asset into the same bucket—margins, feedstock exposure, and electrification angles differ widely.
  3. Monitor EV fluid adoption vs. base-oil supply: Pay attention to how hybrid share, EV thermal fluid specs, and global base-oil capacity shape pricing power into 2027.
  4. Watch supermajor capex priorities: Check Shell and ExxonMobil's ongoing capital allocation updates to see how proceeds—if a sale happens—get routed toward upstream, LNG, or shareholder returns.
JT

Joseph Thompson

Joseph Thompson is known for uncovering stories others miss, combining investigative skills with a knack for accessible, compelling writing.